DocDollars

Hexal AG

Germany · Reporting entity ID 100000071360

Total reported 2019–2025
$18.9M
#335 of 2,960 reporting companies — 0% of all reported industry payments
$311K in general payments across 163 records, plus $18.6M in research funding across 1,452 records.

How it breaks down

General payments $311,035
Research funding $18,594,261

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Hexal AG reported $18.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #335 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 163 general payment records and 1,452 research records were filed.

Common questions about Hexal AG

How much has Hexal AG paid US doctors?

Hexal AG reported $18,905,296 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $311,035 in general payments, $18,594,261 in research funding.

How does Hexal AG rank among drug and device companies?

It ranks #335 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Hexal AG mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.